Preferred Name | Betamethasone | |
Synonyms |
Betamethasone BETAMETHASONE Celestone |
|
Definitions |
A synthetic glucocorticoid with metabolic, immunosuppressive and anti-inflammatory activities. Betamethasone binds to specific intracellular glucocorticoid receptors and subsequently binds to DNA to modify gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C303 |
|
CAS_Registry |
378-44-9 |
|
CHEBI_ID |
CHEBI:3077 |
|
Chemical_Formula |
C22H29FO5 |
|
code |
C303 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
A synthetic glucocorticoid with metabolic, immunosuppressive and anti-inflammatory activities. Betamethasone binds to specific intracellular glucocorticoid receptors and subsequently binds to DNA to modify gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions. |
|
FDA_UNII_Code |
9842X06Q6M |
|
FULL_SYN |
Betamethasone BETAMETHASONE Celestone |
|
label |
Betamethasone |
|
Legacy Concept Name |
Betamethasone |
|
NCI_Drug_Dictionary_ID |
39273 |
|
NSC Number |
39470 |
|
PDQ_Closed_Trial_Search_ID |
39273 |
|
PDQ_Open_Trial_Search_ID |
39273 |
|
Preferred_Name |
Betamethasone |
|
prefixIRI |
Thesaurus:C303 |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
UMLS_CUI |
C0005308 |
|
subClassOf |